Skip to main content
. 2018 Jul 17;19(7):2077. doi: 10.3390/ijms19072077

Figure 2.

Figure 2

Dose-response to selumetinib. Curves of the four cell lines treated with increasing concentration of selumetinib for 144 h. Results of three independent experiments performed in triplicates (detailed data c.f. Table 1). p < 0.05 compared to control (detailed p-values c.f. Table 1).